Anabolic steroids and mental health are connected through possible mood changes, body-image distress, and difficulty stopping use. Aggression is not universal, and these substances do not typically produce a euphoric high. Still, continued use despite harm and depression after stopping can be serious concerns that deserve individual assessment.
Here, anabolic steroids means non-prescribed use of testosterone or testosterone-like substances, not medically indicated treatment. Someone may notice irritability while using, fear losing muscle, or feel depressed after stopping. Those experiences can overlap, but they are not interchangeable diagnoses. General support for substance use and depression and individual addiction counseling can be relevant alongside medical evaluation. The National Institute on Drug Abuse (NIDA) describes both psychiatric risks and substantial differences between people. Its findings do not provide a way to predict your response or change prescribed treatment.
Written by Tim Francis, SUD Content Specialist.
Tim is a nonclinical author. This guide supports discussion with qualified professionals.
How can anabolic steroids affect mood and behavior?
Anabolic steroid misuse can be associated with irritability, anxiety, and major mood changes, but the effects are not uniform. These concerns can overlap with substance use and depression or anger-related substance use problems, without establishing a psychiatric diagnosis or showing that steroids caused every symptom.
NIDA's steroid research summary reports associations with mania, hypomania, and major depression. It also describes reports of anxiety and increased anger. These terms should not be treated as labels for every change in mood. Irritability alone does not establish mania, and a difficult day does not establish major depression. Assessment considers the broader pattern rather than one feeling.
The human evidence includes self-reports, case reports, small studies, and experiments comparing testosterone with placebo. These approaches answer different questions. Reports can identify concerning experiences, while controlled experiments can examine effects under specified conditions. Neither means that every person who misuses steroids will experience the same changes.
Animal and laboratory evidence is separate. NIDA describes animal studies showing changes in brain chemicals involved in mood and reward. One rat study found reduced preference for a sweet reward alongside changes in reward-related brain chemistry. Research using human cells also found interactions with certain GABA receptors. These findings suggest possible mechanisms; they do not directly measure a person's depression, aggression, or likelihood of dependence.
Why do anabolic steroid-related irritability and aggression vary between people?
Aggression is a possible effect, not an inevitable one. Human studies have found different responses across people and sometimes conflicting results. Changes affecting relationships may warrant attention to anger and substance use within one-on-one addiction counseling, but another person's experience cannot predict an individual's response.
Some controlled studies summarized by NIDA found increased irritability or aggressive responses compared with placebo; others did not find that effect. In one study examining mood effects, most participants showed little psychological change, while a few showed prominent manic symptoms. This uneven response is a central finding, not a detail that can be removed from the explanation.
Observational findings also require care. People who use steroids may differ from comparison groups in preexisting characteristics or use of other drugs. These factors can complicate conclusions about how much of a behavioral difference steroids caused. NIDA also notes a possible role for secondary hormonal changes and the possibility that different anabolic steroids have different effects. Neither point provides a reliable personal prediction.
The phrase “roid rage” compresses this mixed evidence into a stereotype. It can encourage people to assume that steroid use always causes violence or, conversely, that staying calm proves there is no problem. Neither conclusion follows. Irritability, threatening behavior, and physical aggression are also different concerns. Harmful behavior deserves attention without requiring someone to prove that steroids were its sole cause.
How can body-image concerns contribute to continued anabolic steroid use?
Body-image distress can make continued steroid use feel tied to confidence or fear of losing muscle. General individual addiction counseling and support for depression alongside substance use can address related concerns, while a persistent preoccupation with perceived inadequate muscularity needs assessment rather than assumptions based on appearance.
NIDA describes an association between steroid use and muscle dysmorphia, a form of body dysmorphic disorder involving preoccupation with muscles being insufficiently large. Some people report using steroids to increase confidence or because they believe training alone can no longer produce the size they want. That association does not mean everyone who lifts weights, wants larger muscles, or uses steroids has this disorder.
The distinction is between an appearance goal and a distressing concern that may shape choices despite harm. NIDA reports that some people give up important activities because they fear missing workouts, breaking dietary restrictions, or losing opportunities to use steroids. It also identifies anxiety about losing muscle as one possible reason attempts to reduce or stop use may not succeed. See NIDA's discussion of body image and continued use.
This helps explain why factual knowledge about health risks may not resolve the difficulty. A person may recognize the harm while still experiencing the prospect of muscle loss as deeply troubling. Care can take that distress seriously without treating continued use as harmless. Body-image distress, dependence, and depression may overlap, but identifying one does not establish the others.
How can anabolic steroid dependence develop without a typical intoxicating high?
Anabolic steroid dependence can develop without a typical euphoric high. Physical dependence involves adaptation and withdrawal; a steroid use disorder concerns a broader harmful pattern of use. Individual substance use counseling and an Intensive Outpatient Program (IOP) address general recovery needs, with the appropriate setting determined through assessment.
NIDA describes continued steroid use despite physical or psychological consequences, substantial time and money spent obtaining steroids, and unsuccessful efforts to reduce use. Maintaining a desired appearance and avoiding unpleasant experiences after stopping may contribute. The absence of immediate intoxication therefore does not establish that someone remains in control of their use.
| Concern | What it describes | Important distinction |
|---|---|---|
| Physical dependence | Adaptation associated with withdrawal after stopping. | Physical adaptation does not describe the person's entire pattern of use. |
| Steroid use disorder | Problematic use involving impaired control and continued use despite harm. | A euphoric high is not required for concern. |
| Body-image distress | Distress about appearance, including perceived inadequate muscularity. | Appearance concerns alone do not establish muscle dysmorphia or dependence. |
| Mood symptoms | Experiences such as irritability, anxiety, or depression. | A symptom alone does not establish its cause or a psychiatric disorder. |
Patterns described by NIDA include:
- Repeated attempts to reduce steroid use without success.
- Continued use despite physical or psychological problems.
- Other important activities displaced by steroid-related priorities.
- Withdrawal symptoms or cravings after stopping.
This is not a self-diagnosis checklist. NIDA's treatment overview describes substance use disorders through patterns of symptoms and behavior assessed together. One sign may deserve attention without proving a disorder. Conversely, the ability to work, exercise, or appear composed does not answer every question about control and harm.
Why can depression after stopping anabolic steroids need medical attention?
Depression after stopping anabolic steroids can be part of withdrawal and may contribute to resuming use. It deserves assessment rather than being dismissed as lost motivation. Support for substance use with depression and private addiction counseling can complement medical evaluation, but does not replace attention to possible hormonal and psychiatric concerns.
NIDA lists fatigue, restlessness, appetite loss, insomnia, reduced sex drive, and steroid cravings among possible withdrawal symptoms. Depression is particularly concerning because it can sometimes involve suicidal behavior. NIDA also explains that steroid misuse disrupts normal hormone production and that care may need to address hormone-related problems alongside mood symptoms. See its discussion of steroid withdrawal and treatment needs.
The timing of symptoms matters, but timing alone does not establish their cause. Feeling depressed after stopping does not tell someone whether withdrawal, an existing mood disorder, body-image distress, another substance, or several concerns are involved. It also does not establish how long symptoms will last. A general article cannot supply a personal recovery deadline or determine whether symptoms will resolve without care.
Depression may also make continued use feel like a solution to the discomfort of stopping. That possibility helps explain resumption of use; it is not evidence that resuming steroids is a safe treatment. The medical and mental health concerns need attention together rather than a self-directed steroid or post-cycle regimen.
For thoughts of suicide or a mental health crisis, call or text 988. For immediate danger, call 911. These crisis resources listed by NIDA are separate from routine outpatient contact.
How can care address anabolic steroid use, mood symptoms, and underlying concerns together?
Care can consider steroid exposure, mood symptoms, body-image distress, and other substance use together, rather than treating one concern as the full explanation. Choice's Intensive Outpatient Program (IOP) and outpatient contact options provide a way to discuss general recovery support alongside medical and mental health care.
NIDA recommends addressing the underlying reasons for steroid use. Its general treatment overview also explains that co-occurring health conditions are usually better addressed alongside substance use concerns rather than separately. This supports a connected assessment, not an assumption that all symptoms have one cause or require the same treatment.
Relevant areas of care may include:
- Medical concerns, including hormone disruption and symptoms after stopping.
- Mental health concerns, including depression, anxiety, and body-image distress.
- Substance use concerns, including impaired control and other drug use.
These areas have different purposes. Medical evaluation can address physical and hormonal concerns. Mental health assessment can distinguish symptoms from a diagnosable condition and consider their relationship to steroid exposure. Substance use care can examine continued use despite harm and the concerns that make change difficult. Treating depression alone may leave body-image distress or a harmful use pattern unaddressed; discussing behavior alone may leave medical concerns unexplained.
Choice serves adults age 18 and older. Its IOP in Albuquerque, NM, includes weekly group and individual therapy, education about substance use disorder, and recovery tools. These are general outpatient services, not evidence of a steroid-specific treatment program. Medical and psychiatric needs may require additional care, and a general program description cannot establish individual fit.
Frequently asked questions about anabolic steroids and mental health
Does everyone who misuses anabolic steroids become aggressive?
No. NIDA describes highly variable responses, and some human studies have not found increased aggression. Others have found increased irritability or aggressive responses. These findings support taking behavioral changes seriously without assuming that every person becomes violent. A calm outward appearance also does not rule out dependence, depression, or other harm.
Can anabolic steroid use be associated with mania or depression?
Yes. NIDA reports associations between anabolic steroid misuse and mania, hypomania, and major depression. Effects are not uniform across people. These associations do not establish that a particular mood change is a psychiatric disorder or that steroids are its only cause. Individual assessment considers steroid exposure alongside other medical and mental health concerns.
Can concern about losing muscle contribute to continued steroid use?
Yes. NIDA identifies anxiety about losing muscle as one possible reason people have difficulty reducing or stopping steroid use. It also describes an association with muscle dysmorphia, a preoccupation with perceived inadequate muscularity. Wanting larger muscles does not itself establish that disorder, but distress and continued use despite harm deserve attention.
Can depression occur after anabolic steroid use stops?
Yes. Depression can occur after stopping anabolic steroids and may be part of withdrawal. Other possible symptoms include fatigue, sleep problems, appetite loss, and cravings. Depression should not be dismissed as a motivation problem or given a guaranteed recovery deadline. Assessment can consider withdrawal, hormonal concerns, existing mood conditions, and other contributors.
Does a lack of euphoria rule out a substance use disorder?
No. Anabolic steroids do not typically produce a euphoric high, yet some people develop a harmful pattern of use. Continued use despite consequences, difficulty cutting down, and steroid-related priorities displacing important activities may be relevant. A diagnosis depends on assessment of the broader pattern, not on whether someone experiences intoxication or euphoria.
Sources
- NIDA: Anabolic Steroids and Other Appearance and Performance Enhancing Drugs
- NIDA: Treatment
- Choice Recovery Path: Intensive Outpatient Program
- Choice Recovery Path: Contact and adult outpatient access information
If you would like to consider general outpatient recovery support, you can review Choice's IOP or use the Choice contact page. A conversation can clarify current services and next steps without requiring you to know which care you need.

